/PRNewswire/ GT Medical Technologies, Inc. announced the enrollment of the first patient into the GESTALT (GammaTile Enhanced Stupp ALTernative Trial) of.
/PRNewswire/ For his invention of GammaTile® Therapy used to treat operable brain tumors, David Brachman, M.D. is the 2022 winner of the Mensa Foundation s.
/PRNewswire/ Shane Brown has joined GT Medical Technologies as its chief commercial officer. In this role, he will oversee all aspects of the company s.